Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.
Mariani
Stefania
S
Department of Medical Physiopathology, Sapienza University, Policlinico Umberto I, 00161 Rome, Italy.
Giona
Fiorina
F
Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.
Basciani
Sabrina
S
Department of Medical Physiopathology, Sapienza University, Policlinico Umberto I, 00161 Rome, Italy; Department of Medical Sciences, Cardiovascular Research Unit, IRCCS San Raffaele, Tosinvest Sanità, Rome, Italy.
Brama
Marina
M
Department of Medical Physiopathology, Sapienza University, Policlinico Umberto I, 00161 Rome, Italy.
Gnessi
Lucio
L
Department of Medical Physiopathology, Sapienza University, Policlinico Umberto I, 00161 Rome, Italy. Electronic address: lucio.gnessi@uniroma1.it.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides; D015519:Bone Density / Q000187:drug effects*; D002648:Child; D005640:Follicle Stimulating Hormone / Q000097:blood; D006177:Gynecomastia / Q000139:chemically induced; D006801:Humans; D000068877:Imatinib Mesylate; D007265:Inhibins / Q000097:blood; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011627:Puberty / Q000187:drug effects*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; C422364:inhibin B; D007265:Inhibins; D000068877:Imatinib Mesylate; D005640:Follicle Stimulating Hormone